OLUBUNMI OLAWALE: Open Payments
NPI 1669953071 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 13 payments from 4 companies in 2025. Trend: 2023 $542 · 2024 $186 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $413 |
| Janssen Pharmaceuticals, Inc | 2 | $168 |
| Axsome Therapeutics, Inc. | 3 | $140 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: CAPLYTA, Auvelity, INVEGA SUSTENNA, SPRAVATO, REXULTI.
Industry payments across MA — which companies pay providers there.
